Metoprolol Retard Terapia (Metoprolol Tartrate)

Metoprolol tartrate selectively blocks β1‑adrenergic receptors in the heart, decreasing the effects of adrenaline and noradrenaline. This reduces heart rate, myocardial contractility, and renin release, leading to lower blood pressure and reduced oxygen demand by the heart muscle.

The appropriate dose of Metoprolol Retard Terapia is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of metoprolol tartrate during pregnancy or lactation has not been definitively established. Healthcare providers weigh potential benefits against possible risks before prescribing it to pregnant or nursing individuals. Patients should discuss any concerns with their physician.

To request Metoprolol Retard Terapia, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoprolol tartrate belongs to the beta‑blocker class, which primarily reduces heart rate and contractility. Compared with ACE inhibitors or calcium‑channel blockers, beta‑blockers are especially useful after myocardial infarction and in certain heart‑failure patients, but may be less effective as first‑line therapy for isolated hypertension in some guidelines.

Metoprolol Retard Terapia should be stored at room temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture, direct sunlight and heat sources to maintain stability and potency.

Metoprolol Retard Terapia is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

Serious risks include severe bradycardia, heart block, marked hypotension, bronchospasm in patients with reactive airway disease, and rare allergic reactions. Patients should seek immediate medical attention if they experience fainting, severe dizziness, difficulty breathing, or signs of an allergic response.

Metoprolol Retard Terapia is contraindicated in individuals with known hypersensitivity to metoprolol or other beta‑blockers, those with severe bradycardia, second‑ or third‑degree atrioventricular block without a pacemaker, and patients with uncompensated heart failure or severe asthma/COPD where beta‑blockade could worsen symptoms.